Pharmacists’ Role in Helping Patients Manage COPD | ASHP Midyear
Drug Topics
DECEMBER 12, 2024
Lourdes Cross, PharmD, BCACP, CDCES, discussed chronic obstructive pulmonary disease and how pharmacists are positioned to help patients exacerbations.
Drug Topics
DECEMBER 12, 2024
Lourdes Cross, PharmD, BCACP, CDCES, discussed chronic obstructive pulmonary disease and how pharmacists are positioned to help patients exacerbations.
IDStewardship
DECEMBER 13, 2024
In this article an experienced antimicrobial stewardship pharmacist discusses lessons learned from navigating antimicrobial stewardship metrics. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted 13 December 2024 If you cannot measure it, you cannot determine if you have changedit. Antimicrobial stewardship metrics are essential for identifying, acting on, and re-evaluating opportunities to enhance the safe and appropriateuse of antibiotics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
DECEMBER 9, 2024
Adults with epilepsy are underrepresented in most CBD trials, including common etiologies.
STAT
DECEMBER 12, 2024
Like many Americans, Holden Karau said she was fed up with health insurance. The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk. She said the hassles piled on stress, forced her to pay more out of pocket, and delayed access to care she needed to recover from multiple broken bones.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
DECEMBER 13, 2024
US Senators introduced the bipartisan bill addressing pharmacy benefit managers and their affiliated pharmacies.
Pharmaceutical Technology
DECEMBER 9, 2024
Shares in WuXi AppTec, one of those implicated in the Chinese biotech blacklisting legislation, surged following the omission.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
DECEMBER 12, 2024
Testing of samples taken from a child in California thought to have contracted H5N1 bird flu after drinking raw milk turned up no evidence of influenza viruses, the Centers for Disease Control and Prevention said Thursday. A test run on a sample from the child — who went to a Marin County emergency department last week with a fever and vomiting — had been positive there for flu A.
Drug Topics
DECEMBER 12, 2024
A conversation with Chelsea Keedy, PharmD, BCACP, clinical assistant professor at the University of Georgia.
Fierce Pharma
DECEMBER 13, 2024
Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that involve young children, experts from an FDA advisory panel expressed their | An FDA advisory committeeexamining the halt of a trial of two Moderna respiratory syncytial virus (RSV) vaccines because of severe lower respiratory tract infections (LRTIs)echoed frustration in knowledge gaps about the disease and said that more testing is needed.
Pharmacy Times
DECEMBER 8, 2024
The phase 3 AMPLIFY trial demonstrates that fixed-duration regimens of acalabrutinib and venetoclax, with or without obinutuzumab, significantly improve progression-free survival and deliver manageable safety profiles compared to chemoimmunotherapy in treatment-naive chronic lymphocytic leukemia (CLL).
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
DECEMBER 11, 2024
Gilead said Tuesday that it will soon begin Phase 3 testing for a drug it believes could prevent HIV infection with just a single shot every year. Such a medicine, if proven effective, would be the closest thing to a vaccine the HIV field has produced in four decades of research. The company plans to begin the trial next year, with an eye toward regulatory filings in late 2027.
Drug Topics
DECEMBER 11, 2024
Ethan Melillo, PharmD, CDOE, senior manager of Integrated Health at LOral, provides some of his favorite recommendations to help with irritated skin.
Pharmaceutical Technology
DECEMBER 12, 2024
In the letter, 77 Nobel Prize winners argue that appointing RFK as Secretary of HHS would put the US publics health in jeopardy.
Pharmacy Times
DECEMBER 11, 2024
The combination vaccine candidates will be evaluated in 2 separate phase 1/2 clinical trials.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
DECEMBER 10, 2024
The Ohio Supreme Court ruled that three of the largest pharmacy chain operators in the U.S. could not be held liable under a state nuisance law for contributing to the long-running opioid crisis. In a 5-to-2 vote, the court determined that the law barred two Ohio counties from obtaining a $650.9 million judgement that was won in a federal court against CVS Health, Walgreens, and Walmart.
Drug Topics
DECEMBER 8, 2024
Navigating Cannabis use requires more than just an understanding of the endocannabinoid system.
Pharmaceutical Technology
DECEMBER 12, 2024
Puberty blockers for people aged under 18 with gender dysphoria will be indefinitely banned by the UK Government.
Pharmacy Times
DECEMBER 11, 2024
According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58% expect Medicare will require pharmacist involvement.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
DECEMBER 12, 2024
Editas Medicine said Thursday afternoon it will lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell disease and shifts focus. The cuts come amid a prolonged financial downturn for the gene-editing field, as valuations have plummeted and layoffs have become widespread. Editas already laid off staff as part of a restructuring in 2023.
Drug Topics
DECEMBER 12, 2024
Nina Vadiei, PharmD, BCPP, discusses some of the challenges she faces working with forensic patients who have been charged with a crime and have severe mental illness.
Pharmaceutical Technology
DECEMBER 12, 2024
Sanofi has announced that its two combination vaccine candidates have received fast track status from the US FDA.
Pharmacy Times
DECEMBER 9, 2024
Pharmacists play a key role in vaccination efforts to prevent respiratory illnesses.
STAT
DECEMBER 10, 2024
Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major drugmaker to do so, CEO David Ricks said Tuesday. Emerging research suggests that GLP-1 drugs — Zepbound is one such treatment — not only reduce food cravings but may also suppress desires for other substances.
European Pharmaceutical Review
DECEMBER 11, 2024
LOG Pharma Primary Packaging is set to present its new barrier eco line at Pharmapack Europe 2025. The new bottles for pharmaceuticals offer optimal oxygen scavenging. Our R&D team has developed a series of barrier bottles that provide exceptional protection against oxygen and moisture while being environmentally friendly and reducing costs significantly, stated LOGs Chief Executive Officer Shaul Bassi.
Pharmaceutical Technology
DECEMBER 11, 2024
When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a handful said yes.
Pharmacy Times
DECEMBER 9, 2024
Luca Bertamini, MD highlights the potential clinical implications of using circulating tumor cells as a biomarker in patients with newly-diagnosed multiple myeloma.
STAT
DECEMBER 12, 2024
As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. There’s more to life than protein folding.
The Checkup by Singlecare
DECEMBER 10, 2024
Trulicity (dulaglutide) and Ozempic (semaglutide) are both brand-name medications approved by the Food and Drug Administration (FDA) to help treat Type 2 diabetes. Because these drugs suppress appetite, some healthcare providers prescribe them off-label for weight loss. However, another medication with the same active ingredient as Ozempic has been FDA approved for weight loss and is sold under the brand name Wegovy.
Pharmaceutical Technology
DECEMBER 9, 2024
Citryll has secured an oversubscribed Series B funding round, raising 85m ($89.8m) to advance the clinical development of CIT-013.
Pharmacy Times
DECEMBER 9, 2024
The phase 3 CEPHEUS trial demonstrated that adding daratumumab (DARA) to the VRd regimen significantly improves minimal residual disease negativity, progression-free survival, and overall response in transplant-ineligible or transplant deferred patients with newly diagnosed multiple myeloma, establishing a new standard of care.
STAT
DECEMBER 8, 2024
SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a panel discussion among sickle cell experts Saturday at STAT@ASH , which took place during the American Society of Hematology’s annual meeting. They said patients were despondent over how suddenly the drug was pulled from the market in September because there had been no clear indication of problems in advance of the announcement.
Pharmafile
DECEMBER 13, 2024
13 December 2024 Amsterdam, the Netherlands CPHI Milan the worlds largest pharma event hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased dealmaking on site. The events success is widely used as a proxy for overall growth in global pharma […] The post Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance appeared first on Pharmafile.
Pharmaceutical Technology
DECEMBER 9, 2024
The US FDA has granted priority review to AstraZeneca's sBLA for Imfinzi (durvalumab) for muscle-invasive bladder cancer (MIBC) treatment.
Let's personalize your content